Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: Dr. Lal PathLabs Limited

Market Cap 27TCr 279.65Cr 242.03Cr 223.13Cr 208.75Cr 389.52Cr 398.27Cr 2.65TCr 1.03TCr 13TCr 1.05TCr 1.03TCr 45TCr P/E Ratio 2026
43.2x
P/E Ratio 2027 * 45.2x
Enterprise Value 25TCr 266.78Cr 230.9Cr 212.87Cr 199.14Cr 371.59Cr 379.95Cr 2.53TCr 980.76Cr 12TCr 1TCr 979.93Cr 43TCr EV / Sales 2026
7.45x
EV / Sales 2027 * 8.03x
Free-Float
44.94%
Yield 2026 *
0.88%
Yield 2027 * 1.13%
1 day+1.58%
1 week+1.52%
Current month-0.86%
1 month-3.41%
3 months+15.62%
6 months+10.88%
Current year+7.48%
1 week 1,500.1
Extreme 1500.1
1,624.8
1 month 1,500.1
Extreme 1500.1
1,719.9
Current year 1,272.6
Extreme 1272.6
1,719.9
1 year 1,272.6
Extreme 1272.6
1,770
3 years 958.02
Extreme 958.025
1,826.98
5 years 881.02
Extreme 881.025
2,122.75
10 years 361.52
Extreme 361.525
2,122.75
Manager TitleAgeSince
Chief Executive Officer - 21/05/2024
Director of Finance/CFO - 10/08/2018
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 75 01/04/2020
Director/Board Member 70 14/02/1995
Director/Board Member 65 22/07/2005
Date Insider Type Main position Quantity % Market Cap.
24/25/24Buy 750 0.0009%
19/25/19Buy

Chief Executive Officer

1,000 0.0012%
19/25/19Sell 350 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
+1.58%+1.52%+7.67%+62.96% 275.3Cr
+0.65%-2.52%+29.83%+337.66% 3.1TCr
-0.33%+2.70%+3.10%+19.36% 2.2TCr
0.00%+7.93%-23.87%-41.96% 703.55Cr
-0.53%+9.66%+0.07%+78.13% 457.34Cr
-2.48%-4.15%-21.58%-67.83% 165.13Cr
+6.68%+0.51%-19.57%+737.89% 161.27Cr
-3.16%-0.07%+15.43%-5.17% 155.81Cr
+0.78%-2.33%+11.87%-34.39% 150.09Cr
+0.53%+0.57%+45.27%-29.61% 146.88Cr
Average +0.36%+3.82%+4.82%+105.71% 751.87Cr
Weighted average by Cap. +0.25%+3.72%+11.81%+161.01%

Financials

2026 2027 *
Net sales 2.74TCr 29Cr 25Cr 23Cr 21Cr 40Cr 41Cr 272.89Cr 105.83Cr 1.33TCr 108.06Cr 105.74Cr 4.62TCr 3.13TCr 33Cr 28Cr 26Cr 25Cr 46Cr 47Cr 311.79Cr 120.92Cr 1.52TCr 123.47Cr 120.82Cr 5.28TCr
Net income 503.5Cr 5.29Cr 4.57Cr 4.22Cr 3.95Cr 7.36Cr 7.53Cr 50Cr 19Cr 243.84Cr 20Cr 19Cr 847.97Cr 590.7Cr 6.2Cr 5.37Cr 4.95Cr 4.63Cr 8.64Cr 8.83Cr 59Cr 23Cr 286.07Cr 23Cr 23Cr 994.83Cr
Net Debt -1.23TCr -13Cr -11Cr -10Cr -9.61Cr -18Cr -18Cr -121.98Cr -47Cr -593.68Cr -48Cr -47Cr -2.06TCr -1.49TCr -16Cr -14Cr -12Cr -12Cr -22Cr -22Cr -148.3Cr -58Cr -721.79Cr -59Cr -57Cr -2.51TCr
Logo Dr. Lal PathLabs Limited
Dr. Lal PathLabs Limited is an India-based provider of diagnostic and related healthcare tests and services. The Company is engaged primarily in the business of running laboratories for carrying out pathological investigations in various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It offers a range of tests, including Pregnancy Test, Full Body Checkups, Covid 19 Test, Heart Test, Kidney Test, Liver Test, Cholesterol Test, Hepatitis B Test, Kidney Function Test, Sugar Test, Thyroid Test, Typhoid Test, Uric Acid Test, Vitamin B12 Test and vitamin D Test. It has approximately 298 clinical laboratories (including National Reference Lab at Delhi, Regional Reference Lab in Kolkata, Bangalore and Mumbai), 6,607 patient service centers, and 12,365 pick-up points (PUPs). Its customers include individual patients, hospitals, and corporate customers.
Employees
4,980
Date Price Change Volume
11/26/11 1,593.50 +1.58% 3,69,662
10/26/10 1,568.70 -0.45% 1,84,518
09/26/09 1,575.80 +1.93% 1,26,213
08/26/08 1,545.90 +0.59% 3,42,382
05/26/05 1,536.90 -1.56% 2,28,362
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
1,593.50INR
Average target price
1,686.00INR
Spread / Average Target
+5.80%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LALPATHLAB Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!